v1
Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
Identifier:nobleid.org/w1/20260515/CCC17B72
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CCC17B72)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims